Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Goodwin Institute for Cancer Research (GICR) was a non-profit research organization based in Plantation, Florida, dedicated to the study of cancer pathogenesis and the development of novel therapeutics. Founded in 1959, the institute specialized in providing contract research services, particularly in oncology-related animal models and monoclonal antibody production. GICR was well-known for its expertise in developing and maintaining specialized mouse models, including germ-free and immunodeficient strains, for cancer research. In 2014, the institute's assets and operations were integrated into Nova Southeastern University (NSU) to bolster the university's bioscience and cancer research capabilities, eventually becoming part of the NSU Cell Therapy Institute.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Goodwin Institute for Cancer Research.